IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BASHAR ALZAHABI

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1467448456
CMS profile
111103
Location
CHARLESTON, IL

General Payments · PY2018–2024

$6,088.39

  • Reported across 239 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,449.41

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nephrology IL All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,449.41 52

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $650.25 27
Boehringer Ingelheim Pharmaceuticals, Inc. $253.89 6
Lilly USA, LLC $192.25 5
Otsuka America Pharmaceutical, Inc. $78.12 3
Ardelyx, Inc. $57.89 2
Fresenius USA Marketing, Inc. $45.49 2
CALLIDITAS THERAPEUTICS US INC. $41.24 2
Amgen Inc. $30.60 1
AKEBIA THERAPEUTICS INC $29.34 1
Retrophin, Inc. $26.40 1
Ultragenyx Pharmaceutical Inc. $24.00 1
Bayer HealthCare Pharmaceuticals Inc. $19.94 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $639.58 23
PY2019 $680.51 30
PY2020 $354.75 19
PY2021 $687.61 25
PY2022 $1,188.36 50
PY2023 $1,088.17 40
PY2024 $1,449.41 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $29.34 11/06/2024 Food and Beverage Undisputed 01/23/2026 1145830399 CMS
Amgen Inc. $30.60 10/09/2024 Food and Beverage Undisputed 01/23/2026 1111516005 CMS
Ardelyx, Inc. $22.91 02/12/2024 Food and Beverage Undisputed 01/23/2026 1146668692 CMS
Ardelyx, Inc. $34.98 06/25/2024 Food and Beverage Undisputed 01/23/2026 1146668694 CMS
AstraZeneca Pharmaceuticals LP $24.30 01/08/2024 Food and Beverage Undisputed 01/23/2026 1105886163 CMS
AstraZeneca Pharmaceuticals LP $34.86 01/23/2024 Food and Beverage Undisputed 01/23/2026 1105730721 CMS
AstraZeneca Pharmaceuticals LP $16.38 02/05/2024 Food and Beverage Undisputed 01/23/2026 1104218125 CMS
AstraZeneca Pharmaceuticals LP $17.09 02/20/2024 Food and Beverage Undisputed 01/23/2026 1105516351 CMS
AstraZeneca Pharmaceuticals LP $80.06 02/21/2024 Food and Beverage Undisputed 01/23/2026 1104711437 CMS
AstraZeneca Pharmaceuticals LP $21.49 02/28/2024 Food and Beverage Undisputed 01/23/2026 1104547088 CMS
AstraZeneca Pharmaceuticals LP $18.85 03/06/2024 Food and Beverage Undisputed 01/23/2026 1104260853 CMS
AstraZeneca Pharmaceuticals LP $20.88 04/10/2024 Food and Beverage Undisputed 01/23/2026 1104736245 CMS
AstraZeneca Pharmaceuticals LP $34.10 04/19/2024 Food and Beverage Undisputed 01/23/2026 1104723729 CMS
AstraZeneca Pharmaceuticals LP $26.56 04/23/2024 Food and Beverage Undisputed 01/23/2026 1105516077 CMS
AstraZeneca Pharmaceuticals LP $20.45 05/14/2024 Food and Beverage Undisputed 01/23/2026 1104348664 CMS
AstraZeneca Pharmaceuticals LP $23.13 05/22/2024 Food and Beverage Undisputed 01/23/2026 1104214279 CMS
AstraZeneca Pharmaceuticals LP $9.09 06/03/2024 Food and Beverage Undisputed 01/23/2026 1105865458 CMS
AstraZeneca Pharmaceuticals LP $22.16 06/10/2024 Food and Beverage Undisputed 01/23/2026 1105472187 CMS
AstraZeneca Pharmaceuticals LP $22.54 06/26/2024 Food and Beverage Undisputed 01/23/2026 1105757459 CMS
AstraZeneca Pharmaceuticals LP $22.70 07/18/2024 Food and Beverage Undisputed 01/23/2026 1105228485 CMS
AstraZeneca Pharmaceuticals LP $15.84 08/01/2024 Food and Beverage Undisputed 01/23/2026 1105550076 CMS
AstraZeneca Pharmaceuticals LP $25.89 08/07/2024 Food and Beverage Undisputed 01/23/2026 1104586724 CMS
AstraZeneca Pharmaceuticals LP $21.95 08/26/2024 Food and Beverage Undisputed 01/23/2026 1105718504 CMS
AstraZeneca Pharmaceuticals LP $24.73 09/03/2024 Food and Beverage Undisputed 01/23/2026 1104410795 CMS
AstraZeneca Pharmaceuticals LP $21.56 09/17/2024 Food and Beverage Undisputed 01/23/2026 1105737397 CMS
AstraZeneca Pharmaceuticals LP $21.69 10/02/2024 Food and Beverage Undisputed 01/23/2026 1105666768 CMS
AstraZeneca Pharmaceuticals LP $22.56 10/15/2024 Food and Beverage Undisputed 01/23/2026 1104753960 CMS
AstraZeneca Pharmaceuticals LP $21.37 10/30/2024 Food and Beverage Undisputed 01/23/2026 1105865494 CMS
AstraZeneca Pharmaceuticals LP $22.18 11/19/2024 Food and Beverage Undisputed 01/23/2026 1105597713 CMS
AstraZeneca Pharmaceuticals LP $18.51 12/03/2024 Food and Beverage Undisputed 01/23/2026 1104669371 CMS
AstraZeneca Pharmaceuticals LP $19.33 12/16/2024 Food and Beverage Undisputed 01/23/2026 1105845015 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.94 09/25/2024 Food and Beverage Undisputed 01/23/2026 1086131008 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $33.48 01/24/2024 Food and Beverage Undisputed 01/23/2026 1118020550 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.05 03/04/2024 Food and Beverage Undisputed 01/23/2026 1118020546 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $106.07 03/27/2024 Food and Beverage Undisputed 01/23/2026 1118020554 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.29 04/16/2024 Food and Beverage Undisputed 01/23/2026 1118020548 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $36.94 05/08/2024 Food and Beverage Undisputed 01/23/2026 1118020552 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.06 10/17/2024 Food and Beverage Undisputed 01/23/2026 1118020544 CMS
CALLIDITAS THERAPEUTICS US INC. $18.08 09/18/2024 Food and Beverage Undisputed 01/23/2026 1141522345 CMS
CALLIDITAS THERAPEUTICS US INC. $23.16 10/08/2024 Food and Beverage Undisputed 01/23/2026 1141524206 CMS
Fresenius USA Marketing, Inc. $22.80 03/06/2024 Food and Beverage Undisputed 01/23/2026 1154205080 CMS
Fresenius USA Marketing, Inc. $22.69 05/07/2024 Food and Beverage Undisputed 01/23/2026 1154205078 CMS
Lilly USA, LLC $76.16 06/20/2024 Food and Beverage Undisputed 01/23/2026 1136058434 CMS
Lilly USA, LLC $34.89 07/02/2024 Food and Beverage Undisputed 01/23/2026 1136062478 CMS
Lilly USA, LLC $29.41 08/08/2024 Food and Beverage Undisputed 01/23/2026 1136058436 CMS
Lilly USA, LLC $25.29 11/12/2024 Food and Beverage Undisputed 01/23/2026 1136063348 CMS
Lilly USA, LLC $26.50 12/11/2024 Food and Beverage Undisputed 01/23/2026 1136074535 CMS
Otsuka America Pharmaceutical, Inc. $25.95 01/29/2024 Food and Beverage Undisputed 01/23/2026 1118852292 CMS
Otsuka America Pharmaceutical, Inc. $26.39 04/30/2024 Food and Beverage Undisputed 01/23/2026 1118852294 CMS
Otsuka America Pharmaceutical, Inc. $25.78 09/10/2024 Food and Beverage Undisputed 01/23/2026 1118852296 CMS
Travere Therapeutics, Inc. $26.40 01/03/2024 Food and Beverage Undisputed 01/23/2026 1149942088 CMS
Ultragenyx Pharmaceutical Inc. $24.00 10/10/2024 Food and Beverage Undisputed 01/23/2026 1153283645 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.